Johannes von Büren

Medicine · Health Sciences

6h-index89citations14works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sexual function and dysfunction studies(4), Dermatology and Skin Diseases(4), Hair Growth and Disorders(4), Sexuality, Behavior, and Technology(3), Dermatologic Treatments and Research(2)

Publications14 total

Sequencing AI Automation and Data Interoperability in Oncology: A Scenario-Planning Framework Coupled With Discrete-Event Simulation (Preprint)
2026Open Access
Head-to-head Comparison of the Safety and Efficacy Profiles of Three Phosphodiesterase Type 5 Inhibitors through Patient-reported Outcomes of 130 000 Patients from a Direct-to-consumer Platform Database
European Urology Focus·2025Open Access
Evaluating Patient-Reported Adherence And Safety for Oral Contraception Treatment in Women via a Direct-To-Consumer Prescription Platform: A Cross-Sectional Study
Telemedicine Journal and e-Health·2024· 1 cited
Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
Journal of Cosmetic Dermatology·2024· 8 citedOpen Access
Selbsttestung bei sexuell übertragbaren Infektionen (STI): Ein Schritt für die Digitalisierung in der Medizin
Trillium Diagnostik·2024
Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study
Telemedicine Reports·2023· 1 citedOpen Access
Reply to Eugenio Ventimiglia, Andrea Salonia, and Francesco Montorsi’s Letter to the Editor re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focus 2022;8:794–802
European Urology Focus·2023
Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia
Clinical Cosmetic and Investigational Dermatology·2023· 6 citedOpen Access
Direct-to-Consumer Teledermatology in Germany: A Retrospective Analysis of 1,999 Teleconsultations Suggests Positive Impact on Patient Care
Telemedicine Journal and e-Health·2023· 10 cited
Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
Digital Health·2023· 5 citedOpen Access
A Rejected Hypothesis: Phenomenon of High Treatment Adherence in Direct-to-Consumer Teledermatology Despite Lack of Direct Physician–Patient Interaction
Telemedicine Journal and e-Health·2022· 6 cited
Telemedical care of men with androgenetic alopecia demonstrates improved access to care and patient benefit
Journal of the European Academy of Dermatology and Venereology·2022· 6 cited
Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction
European Urology Focus·2021· 19 citedOpen Access
Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional Study
Sexual Medicine·2020· 27 citedOpen Access

Frequent Co-authors

Florian A. Y. N. Schröder(7), Finn Abeck(6), Julian Kött(6), Inga Hansen(6), Stefan W. Schneider(6), Christian Wülfing(5), Isabell Wiesenhütter(5), Moritz von Büren(4), Christian Gratzke(4), Severin Rodler(3), Edward Garrahy(3), Juliana Veneroso(3), Sabine Brookman‐May(3), Alexander Büchner(2), Christian G. Stief(2), Mattis Bertlich(2), Katja Elkhanova(1), Sven Jungmann(1), Alessandra Rünger(1), Leopold Torster(1)